SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,513,451 | -75.3% | 4,500,000 | -75.8% | 0.00% | -100.0% |
Q4 2022 | $18,285,228 | +101.1% | 18,600,000 | +100.0% | 0.00% | 0.0% |
Q3 2022 | $9,092,000 | +7.2% | 9,300,000 | +6.3% | 0.00% | 0.0% |
Q2 2022 | $8,481,000 | -12.0% | 8,750,000 | -11.2% | 0.00% | – |
Q1 2022 | $9,636,000 | -11.7% | 9,850,000 | -10.5% | 0.00% | -100.0% |
Q4 2021 | $10,909,000 | +11.8% | 11,000,000 | +11.1% | 0.00% | 0.0% |
Q3 2021 | $9,754,000 | -5.0% | 9,900,000 | -4.8% | 0.00% | 0.0% |
Q2 2021 | $10,266,000 | -6.1% | 10,400,000 | -8.0% | 0.00% | 0.0% |
Q1 2021 | $10,934,000 | +30.8% | 11,300,000 | +27.7% | 0.00% | 0.0% |
Q4 2020 | $8,358,000 | +2.0% | 8,850,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $8,195,000 | -6.2% | 8,850,000 | -10.6% | 0.00% | 0.0% |
Q2 2020 | $8,740,000 | -9.8% | 9,900,000 | -16.8% | 0.00% | 0.0% |
Q1 2020 | $9,689,000 | -8.1% | 11,900,000 | +2.4% | 0.00% | 0.0% |
Q4 2019 | $10,548,000 | -2.7% | 11,625,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $10,837,000 | -3.9% | 11,625,000 | +0.9% | 0.00% | 0.0% |
Q2 2019 | $11,276,000 | – | 11,525,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|